IMGM

Biomarkers are of high importance and great value in many life science areas ranging from trait or disease association (e.g. molecular genetics and HLA genotyping) to personalized medicine (e.g. drug discovery and pharmacogenetics). IMGM offers a wide range of services to support you in the discovery of biomarkers. Whether you are doing basic research on some model organism or conducting (pre-) clinical studies, you can count on our in-depth experience and expertise to make your project a success... Tumorigenesis, chromosomal instability and vertical transmissions in germline cells are potential risks of gene therapy or DNA vaccine approaches. To address these issues, regulatory agencies worldwide require pre-clinical in vivo biodistribution studies to evaluate the safety and toxicity of nucleic acid therapeutics. At IMGM, our expert team has long-standing experience in complex assay design and validation, resulting in high-quality data. We design GLP-certified qPCR and ddPCR-based..

Also known as: IMGM Laboratories, IMGM Laboratories GmbH

Registration numbers: HRB 140 496 (W)

VAT numbers: DE813321466

Primary location: Martinsried Germany